Resumen
Approximately 60% of patients with breast cancer require radiotherapy. With significant advances in breast cancer outcomes, an increasing focus is being placed on cancer survivorship, including the reduction of the late effects from radiotherapy. The aim of this review article is to highlight the potential of particle therapy in ensuring comprehensive radiotherapy for patients with breast cancer while reducing normal tissue exposure that can lead to subsequent impairments in quality of life. We review the latest literature in this space for both proton and carbon therapy and highlight opportunities for future study.